Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.
Open | $82.82 |
Close | $80.97 |
Volume / Avg. | 613.84K / 2.62M |
Day Range | 80.60 - 82.82 |
52 Wk Range | 73.68 - 99.56 |
Market Cap | $15.38B |
P/E Ratio | 77.57 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 1.89% |
Days to Cover | 1.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biomarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.
Other companies in Biomarin Pharmaceutical’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
There is no analysis for Biomarin Pharmaceutical.
Biomarin Pharmaceutical has a consensus price target of $95.68.
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $80.975 last updated July 3, 2024 at 1:00 PM EDT.
There are no upcoming dividends for Biomarin Pharmaceutical.
Biomarin Pharmaceutical’s Q2 earnings are confirmed for Monday, July 29, 2024.
There is no upcoming split for Biomarin Pharmaceutical.
Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.